Since 2021, I am assistant professor in Health Technology Assessment (HTA) at the Erasmus University Rotterdam (The Netherlands). My research interests include health economic modelling of haematological diseases as well as pharmaceutical pricing and market access of new (and therefore mostly [very] expensive) cancer drugs.
Whenever possible, I am conducting research in R and am guided by the following principles:
PhD in Health Technology Assessment, 2020
Erasmus University Rotterdam
MSc (Res) in Health Sciences, 2015
BSc in European Public Health, 2013
After huge frustrations with several Markov models in Excel, I decided to change my work routine in 2015. I found R to be a powerful companion and sticked to it ever since.
I am a nurse by background and worked at a university hospital for nearly 10 years. For me, this was the hardest but also most rewarding work of my career.
Homebrewing is one of my favourite hobbies since 2016. If I could programme the entire process in R, I would do it right away.
RETHRIM is an EU sponsored research consortium that has initiated a phase III clinical trial to investigate the usefulness of Mesenchymal Stromal Cells for the treatment of Graft-versus-Host-Disease.